drinking while on glp-1 Altimmune's Drug Reduces Heavy in Alcohol-Use Disorder Trial. Altimmune's pemvidutide achieved a statistically significant reduction in heavy drinking days compared to a placebo in a Phase 2 trial. This peptide glp 1 to stop drinking
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22















/product/41/5015682/1.jpg?5024)






